Health Care Equipment & Services

How Cencora’s $1.1 B eye‑care deal expands its reach into high‑margin retinal services and boosts earnings by $0.04 per share.

Drägerwerk’s record 2025 sales, 20% EBIT rise, soaring order book and third straight dividend hike prove a resilient, shareholder‑friendly growth story that outpaces tough market conditions.

MedMira Inc. powers global health with next‑gen rapid diagnostic tests—despite current losses, its biotech innovation promises growth and improved patient outcomes worldwide.

Abbott Laboratories’ acquisition of Exact Sciences boosts its cancer‑diagnostics reach, adding Cologuard and Oncotype DX to drive high‑margin growth and early‑detection leadership.

Cardinal Health dominates the healthcare supply chain, expanding logistics, fulfillment, and pharma solutions while weathering investor shifts, ensuring robust growth and innovation.

Wuhan Easydiagnosis’s soaring P/E ratio and market volatility reveal a biotech firm’s ambitious POCT innovation yet uncertain future—investors should scrutinize its growth prospects before buying in.

Outset Medical’s focus on advanced hemodialysis tech aims to transform kidney patient care while navigating stock volatility and R&D‑heavy growth.

Well Health Technologies Corp. reports a record 43 % higher Q4 Adjusted EBITDA and $1.40 B revenue for 2025, turning profits, boosting cash flow, and driving growth via strategic acquisitions.

Picard Medical Inc. faces a class‑action lawsuit over alleged stock‑promotion fraud amid claims of artificial‑heart breakthroughs and workplace awards, raising serious governance and investor‑trust concerns.

Avricore Health Inc. faces a sharp decline in stock and a negative P/E, raising red flags about its sustainability in the competitive generic pharmaceutical market.